A five-year rehabilitation programme for younger women after a coronary event reduces the need for hospital care

Scandinavian Journal of Public Health
Agneta AnderssonIngeborg Eriksson

Abstract

Cardiovascular disease (CVD) is the dominant diagnosis in in-patient care in Sweden and the third most common cause for long-term sick leave and disability pension. Women are higher consumers of health care than men and have higher frequencies of sickness absenteeism. The aim of this paper was to evaluate whether a five-year long rehabilitation programme for women with CVD affected the use of hospital care and sickness absenteeism. 130 women below 65 years of age with CVD were randomized to either intervention (n = 69, mean age 52.4 years) with an intensive lifestyle programme (e.g. physical exercise, smoking cessation, dietary advice), including stress management or to standard care (n = 61, mean age 54.3 years). All patients went through baseline medical examinations, including self-administered questionnaires. This procedure was repeated yearly during the rehabilitation period. The frequency of cardiac-related healthcare use was followed via official registers. Emergency visits and number of in-patient days decreased significantly in the intervention group from year one to year five (p < 0.05) but remained unchanged in the control group. Scheduled doctor visits decreased significantly in both groups. There were no significan...Continue Reading

References

Nov 18, 1998·Annals of Neurology·H W Moser, G V Raymond
Jan 15, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M ErikssonK Schenck-Gustafsson
Jun 14, 2002·General Hospital Psychiatry·Sherry L GraceDonna E Stewart
Jun 14, 2002·General Hospital Psychiatry·Sherry L GraceDonna E Stewart
Nov 5, 2002·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Christina M MitchellUNKNOWN Pathways of Choice and Healthy Ways Project Team
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Sep 1, 2004·Journal of the American College of Cardiology·Brandi J WittVéronique L Roger
Oct 30, 2004·Scandinavian Journal of Public Health. Supplement·Peter Allebeck, Arne Mastekaasa
Jan 1, 1997·International Journal of Behavioral Medicine·H Ursin
Jan 1, 1994·International Journal of Behavioral Medicine·K Orth-GomérP Fredlund
Feb 24, 2006·European Heart Journal·José LealMike Rayner
May 17, 2006·Heart·R Luengo-FernándezM Rayner
Jun 10, 2006·Scandinavian Journal of Public Health. Supplement·Johanna Alfredsson
Jun 22, 2006·American Journal of Epidemiology·Hannah KuperElisabete Weiderpass
Jun 27, 2007·General Hospital Psychiatry·Daphne J KorczakAnthony J Levitt
Aug 21, 2007·International Journal of Cardiology·David M EpsteinKeith A A Fox
Aug 21, 2007·Gender Medicine·Kristina Lindwall SundelKarin Schenck-Gustafsson
Nov 7, 2007·European Heart Journal·Wolfgang LindenJocelyne Leclerc
May 1, 2009·Maturitas·Karin Schenck-Gustafsson

❮ Previous
Next ❯

Citations

Apr 9, 2013·Archives of Physical Medicine and Rehabilitation·Natasha Kareem BruscoNora Shields
Jun 4, 2013·Maturitas·Karin Schenck-Gustafsson, Margaret Rees
Dec 22, 2010·Scandinavian Journal of Public Health·Claus Vinther Nielsen, Lucette Kirsten Meillier
Mar 15, 2019·The Cochrane Database of Systematic Reviews·Janice HegewaldAndreas Seidler
Jan 6, 2016·The Cochrane Database of Systematic Reviews·Lindsey AndersonRod S Taylor
Jul 7, 2015·The Cochrane Database of Systematic Reviews·Jürgen BarthJulia A Critchley
Sep 25, 2021·BMC Cardiovascular Disorders·Taslima MamatazSherry L Grace
Nov 7, 2021·The Cochrane Database of Systematic Reviews·Grace DibbenRod S Taylor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.